Current Edition

Volume 15 Issue 3

Automation in Clinical Trials

Increasing Sophistication Requires Strategies for Adoption As clinical trials have become more complex with more moving parts, so too have the requirements for te...
Continue Reading →
Volume 15 Issue 3

Addressing Missing Data in Clinical Trials –The Data Science Approach

Digital Health Technologies (DHTs) have revolutionized clinical trial data collection, while also promising to make research more efficient and more patient-centric....
Continue Reading →
Volume 15 Issue 3

FDA’s New Draft Guidance for Psychedelic Drugs Opens Doors for Drug Developers in the US

In July 2023, Australia became the first country to permit psychiatrists to prescribe 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin for use in psychedelic-...
Continue Reading →
Volume 15 Issue 3

EU CTR Pushes Sponsors and CROs to Clean Up Their Act

The European Medicines Agency’s plan to harmonise all clinical trial information requires a significant change in how companies collect and store trial data and reco...
Continue Reading →
Volume 15 Issue 3

Focus on End-to-end Innovation and Efficiency Drives Life Sciences Service Provider Consolidation

The world has changed in Life Sciences and innovation and efficiency have become key to survival. Pharma manufacturers and marketing authorisation holders in the Lif...
Continue Reading →
Volume 15 Issue 3

Advancing NIPT Workflows:

Using Size Selection to Enrich Fetal Fraction, Enabling Extended Blood Storage in EDTA tubes Prenatal screening for Down’s Syndrome and other chromosomal imbalanc...
Continue Reading →
Volume 15 Issue 3

Unlock Clinical Research Site Potential by Addressing Resource Challenges and Trial Complexity

Staffing and trial enrolment remain the most pressing issues research sites face, according to the 2023 WCG Clinical Research Site Challenges survey. As trial comple...
Continue Reading →
Volume 15 Issue 3

AI for Medical Writers – Friend or Foe?

Artificial Intelligence (AI) is beginning to affect almost every industry, and medical writing is no different. But how does this relate to our industry? How will AI...
Continue Reading →
Volume 15 Issue 3

Using QSP Modeling to Advance Knowledge and Therapeutics for Alzheimer’s and Parkinson’s Disease

This article explores the use of quantitative systems pharmacology (QSP) modeling to provide further insights into the mechanism of action of neurodegenerative disea...
Continue Reading →
Volume 15 Issue 3

Building Robust Clinical Supply Chains to Support Global Trials

As clinical trials become more complex in design, seek to include varying populations and reach patients around the world, having a robust end-to-end supply chain so...
Continue Reading →